可药性
计算生物学
三元络合物
串扰
蛋白质组
泛素
蛋白质降解
药物发现
计算机科学
纳米技术
生物
化学
生化工程
生物信息学
生物化学
工程类
材料科学
酶
基因
电子工程
作者
Jake A. Ward,Carles Perez‐Lopez,Cristina Mayor‐Ruiz
出处
期刊:ChemBioChem
[Wiley]
日期:2023-04-05
卷期号:24 (10): e202300163-e202300163
被引量:39
标识
DOI:10.1002/cbic.202300163
摘要
Abstract Degraders have illustrated that compound‐induced proximity to E3 ubiquitin ligases can prompt the ubiquitination and degradation of disease‐relevant proteins. Hence, this pharmacology is becoming a promising alternative and complement to available therapeutic interventions (e. g., inhibitors). Degraders rely on protein binding instead of inhibition and, hence, they hold the promise to broaden the druggable proteome. Biophysical and structural biology approaches have been the cornerstone of understanding and rationalizing degrader‐induced ternary complex formation. Computational models have now started to harness the experimental data from these approaches with the aim to identify and rationally help design new degraders. This review outlines the current experimental and computational strategies used to study ternary complex formation and degradation and highlights the importance of effective crosstalk between these approaches in the advancement of the targeted protein degradation (TPD) field. As our understanding of the molecular features that govern drug‐induced interactions grows, faster optimizations and superior therapeutic innovations for TPD and other proximity‐inducing modalities are sure to follow.
科研通智能强力驱动
Strongly Powered by AbleSci AI